MoonLake Immunotherapeutics MLTX
NASDAQ MLTX
$10.68 +0.36 (+3.49%)
As of: Oct 21, 2026 · 2:43 PM EDT

MoonLake Immunotherapeutics (MLTX) Notes Payables (2020 - 2022)

Updated

MoonLake Immunotherapeutics' Notes Payables came in at $150,000 for Q1 2022, down 99.0% from the prior quarter.

Analysis

MoonLake Immunotherapeutics (MLTX) Notes Payables (2020 - 2022) Analysis & Trends

At the end of FY2021, MoonLake Immunotherapeutics' Notes Payables was $15 million.

  • Going back by year, Notes Payables was $58,063 in FY2020.
  • The Q1 2022 figure represents the lowest quarterly Notes Payables since Q4 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.92 Bn 1,105.50 Bn 19.71 Bn
2 Johnson & Johnson 617.57 Bn 536.10 Bn 17.26 Bn
3 AbbVie 501.37 Bn 474.48 Bn 12.70 Bn
4 Merck 367.96 Bn 322.33 Bn 12.21 Bn
5 Novartis Ag 297.98 Bn 261.97 Bn 11.24 Bn
6 Astrazeneca 261.45 Bn 235.14 Bn 12.86 Bn
7 Amgen 236.30 Bn 191.70 Bn 7.24 Bn
8 Gilead Sciences 190.27 Bn 164.46 Bn 6.22 Bn
9 Pfizer 169.65 Bn 116.29 Bn 10.94 Bn
10 MoonLake Immunotherapeutics 789.78 Mn -879.61 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 150,000.00
Dec 31, 2021 15.00 Mn
Dec 31, 2020 58,063.00
API Access

MoonLake Immunotherapeutics Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=MLTX&period=max&api_key=YOUR_API_KEY